APLS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $4,747,193.37

Apellis Pharmaceuticals Insider Trading History Chart

Apellis Pharmaceuticals Share Price & Price History

^$16.92

▼ -0.49 (-2.81%)

As of 05/30/2025 03:10 PM ET

Days: 30 | 90 | 365

Apellis Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/17/2025	James George Chopas	CAO	Sell	183	$24.82	$4,542.06	47,955
3/5/2025	David O. Watson	General Counsel	Sell	5,569	$25.10	$139,781.90	138,730
2/11/2025	Mark Jeffrey DeLong	Insider	Sell	363	$28.54	$10,360.02	83,945
1/29/2025	Cedric Francois	CEO	Sell	2,824	$29.52	$83,364.48	415,695
1/29/2025	David O. Watson	General Counsel	Sell	695	$29.52	$20,516.40	144,299
1/29/2025	Nur Nicholson	Insider	Sell	825	$29.52	$24,354.00	83,664
1/29/2025	Timothy Eugene Sullivan	CFO	Sell	546	$29.52	$16,117.92	128,665
1/22/2025	Cedric Francois	CEO	Sell	13,551	$30.43	$412,356.93	418,519
1/22/2025	David O. Watson	General Counsel	Sell	3,323	$30.43	$101,118.89	144,994
1/22/2025	James George Chopas	CAO	Sell	1,096	$30.43	$33,351.28	48,138
1/22/2025	Nur Nicholson	Insider	Sell	3,948	$30.43	$120,137.64	84,489
1/22/2025	Timothy Eugene Sullivan	CFO	Sell	3,088	$30.43	$93,967.84	129,211
1/17/2025	Cedric Francois	CEO	Sell	6,007	$29.96	$179,969.72	301,408
1/17/2025	David O. Watson	General Counsel	Sell	2,201	$29.96	$65,941.96	105,555
1/17/2025	James George Chopas	CAO	Sell	715	$29.96	$21,421.40	36,643
1/17/2025	Nur Nicholson	Insider	Sell	2,145	$29.96	$64,264.20	52,011
1/17/2025	Timothy Eugene Sullivan	CFO	Sell	1,730	$29.96	$51,830.80	86,370
1/13/2025	Cedric Francois	CEO	Sell	6,247	$28.70	$179,288.90	307,415
1/13/2025	David O. Watson	General Counsel	Sell	4,965	$28.70	$142,495.50	107,756
1/13/2025	James George Chopas	CAO	Sell	783	$28.70	$22,472.10	37,358
1/13/2025	Jeffrey Eisele	Insider	Sell	264	$28.70	$7,576.80	56,881
1/13/2025	Timothy Eugene Sullivan	CFO	Sell	2,170	$28.70	$62,279.00	88,100
1/6/2025	Caroline Baumal	Insider	Sell	2,816	$33.81	$95,208.96	55,560
12/23/2024	Jeffrey Eisele	Insider	Sell	63	$33.09	$2,084.67	57,145
9/16/2024	A. Sinclair Dunlop	Director	Sell	37,000	$36.23	$1,340,510.00	100,000
6/21/2024	A. Sinclair Dunlop	Director	Sell	37,000	$39.24	$1,451,880.00	136,998
5/8/2024	Pascal Deschatelets	Insider	Sell	78,907	$42.35	$3,341,711.45	1,115,983
4/8/2024	Pascal Deschatelets	Insider	Sell	69,107	$54.17	$3,743,526.19	1,115,983
4/1/2024	Timothy Eugene Sullivan	CFO	Sell	4,000	$58.66	$234,640.00	93,338
3/19/2024	A. Sinclair Dunlop	Director	Sell	18,681	$57.18	$1,068,179.58	173,998
3/18/2024	Mark Jeffrey DeLong	Insider	Sell	9,913	$56.90	$564,049.70	54,693
3/15/2024	James George Chopas	CAO	Sell	184	$56.46	$10,388.64	38,883
3/13/2024	Nur Nicholson	Insider	Sell	11,220	$57.56	$645,823.20	56,287
3/1/2024	Cedric Francois	CEO	Sell	250,000	$64.11	$16,027,500.00	313,662
3/1/2024	Timothy Eugene Sullivan	CFO	Sell	6,000	$63.22	$379,320.00	93,338
2/12/2024	Adam J. Townsend	Insider	Sell	1,148	$67.77	$77,799.96	92,453
2/12/2024	Cedric Francois	CEO	Sell	3,962	$67.77	$268,504.74	313,662
2/12/2024	David O. Watson	General Counsel	Sell	781	$67.77	$52,928.37	103,390
2/12/2024	Timothy Eugene Sullivan	CFO	Sell	1,431	$67.77	$96,978.87	93,338
1/29/2024	Cedric Francois	CEO	Sell	2,843	$64.14	$182,350.02	317,624
1/29/2024	David O. Watson	General Counsel	Sell	906	$64.14	$58,110.84	104,171
1/29/2024	Nur Nicholson	Insider	Sell	835	$64.14	$53,556.90	67,507
1/22/2024	Adam J. Townsend	Insider	Sell	3,413	$65.00	$221,845.00	94,507
1/22/2024	Cedric Francois	CEO	Sell	13,431	$65.00	$873,015.00	320,467
1/22/2024	David O. Watson	General Counsel	Sell	4,184	$65.00	$271,960.00	105,077
1/22/2024	James George Chopas	CAO	Sell	1,061	$65.00	$68,965.00	39,067
1/22/2024	Timothy Eugene Sullivan	CFO	Sell	3,551	$65.00	$230,815.00	95,675
1/16/2024	Cedric Francois	CEO	Sell	7,851	$66.81	$524,525.31	333,898
1/16/2024	David O. Watson	General Counsel	Sell	4,240	$66.81	$283,274.40	109,261
1/16/2024	James George Chopas	CAO	Sell	864	$66.81	$57,723.84	40,128
1/16/2024	Jeffrey Eisele	Insider	Sell	438	$66.81	$29,262.78	72,650
1/16/2024	Timothy Eugene Sullivan	CFO	Sell	2,235	$66.81	$149,320.35	99,226
1/4/2024	Caroline Baumal	Insider	Sell	2,751	$60.05	$165,197.55	32,931
12/26/2023	Jeffrey Eisele	Insider	Sell	68	$57.86	$3,934.48	53,815
12/19/2023	David O. Watson	General Counsel	Sell	3,905	$57.23	$223,483.15	89,753
12/1/2023	Lukas Scheibler	Insider	Sell	10,000	$60.00	$600,000.00	68,299
11/21/2023	Cedric Francois	CEO	Sell	5,000	$48.80	$244,000.00	269,655
11/17/2023	Alec Machiels	Director	Sell	1,250	$47.74	$59,675.00	367,420
11/8/2023	Pascal Deschatelets	Insider	Sell	12,000	$47.27	$567,240.00	1,071,807
10/23/2023	James George Chopas	CAO	Sell	132	$46.04	$6,077.28	32,680
10/23/2023	Mark Jeffrey DeLong	Insider	Sell	131	$46.04	$6,031.24	51,622
10/17/2023	Alec Machiels	Director	Sell	1,250	$48.50	$60,625.00	367,420
10/9/2023	Pascal Deschatelets	Insider	Sell	12,000	$40.38	$484,560.00	1,066,313
9/18/2023	Alec Machiels	Director	Sell	1,250	$45.00	$56,250.00	367,420
9/18/2023	Nur Nicholson	Insider	Sell	20,350	$44.27	$900,894.50	53,284
9/15/2023	Alec Machiels	Director	Sell	1,250	$45.34	$56,675.00	367,420
9/8/2023	Pascal Deschatelets	Insider	Sell	12,000	$42.87	$514,440.00	1,059,813
9/1/2023	Cedric Francois	CEO	Sell	150,000	$41.75	$6,262,500.00	424,655
8/31/2023	James George Chopas	CAO	Sell	551	$41.23	$22,717.73	30,312
8/8/2023	Pascal Deschatelets	Insider	Sell	12,000	$23.66	$283,920.00	1,053,313
7/17/2023	Alec Machiels	Director	Sell	1,250	$64.79	$80,987.50	267,641
7/10/2023	Pascal Deschatelets	Insider	Sell	12,000	$84.55	$1,014,600.00	1,046,813
7/3/2023	David O. Watson	General Counsel	Sell	8,510	$89.98	$765,729.80	85,753
7/3/2023	Timothy Eugene Sullivan	CFO	Sell	6,779	$89.97	$609,906.63	77,713
6/20/2023	Alec Machiels	Director	Sell	1,250	$88.41	$110,512.50	267,641
6/8/2023	Pascal Deschatelets	Insider	Sell	12,000	$91.35	$1,096,200.00	1,040,313
6/5/2023	Timothy Eugene Sullivan	CFO	Sell	69,779	$88.80	$6,196,375.20	77,713
6/1/2023	Karen Lewis	Insider	Sell	5,000	$86.00	$430,000.00	41,504
5/17/2023	Alec Machiels	Director	Sell	1,250	$88.66	$110,825.00	267,641
5/16/2023	Cedric Francois	CEO	Sell	30,000	$85.66	$2,569,800.00	274,655
5/8/2023	Pascal Deschatelets	Insider	Sell	12,000	$92.39	$1,108,680.00	1,033,813
5/3/2023	Adam J. Townsend	Insider	Sell	5,000	$82.71	$413,550.00	75,995
4/18/2023	Cedric Francois	CEO	Sell	30,000	$82.02	$2,460,600.00	637,601
4/17/2023	Alec Machiels	Director	Sell	1,250	$81.05	$101,312.50	267,641
4/10/2023	Pascal Deschatelets	Insider	Sell	12,000	$78.21	$938,520.00	1,027,313
4/3/2023	A. Sinclair Dunlop	Director	Sell	500	$74.05	$37,025.00	131,297
4/3/2023	Karen Lewis	Insider	Sell	5,000	$75.00	$375,000.00	41,430
3/21/2023	Cedric Francois	CEO	Sell	30,000	$62.74	$1,882,200.00	1,144,591
3/17/2023	Alec Machiels	Director	Sell	1,250	$64.03	$80,037.50	267,641
3/8/2023	Pascal Deschatelets	Insider	Sell	12,000	$63.79	$765,480.00	1,020,813
2/23/2023	Jeffrey Eisele	Insider	Sell	1,646	$68.76	$113,178.96	53,883
2/8/2023	Pascal Deschatelets	Insider	Sell	12,000	$54.45	$653,400.00	1,006,756
2/3/2023	Adam J. Townsend	Insider	Sell	5,000	$55.85	$279,250.00	67,932
1/30/2023	Jeffrey Eisele	Insider	Sell	883	$52.76	$46,587.08	46,468
1/23/2023	Karen Lewis	Insider	Sell	2,955	$51.58	$152,418.90	37,709
1/17/2023	Alec Machiels	Director	Sell	1,250	$52.42	$65,525.00	267,641
1/9/2023	Pascal Deschatelets	Insider	Sell	12,000	$46.08	$552,960.00	983,780
1/5/2023	Federico Grossi	Insider	Sell	2,500	$48.79	$121,975.00	94,884
1/3/2023	A. Sinclair Dunlop	Director	Sell	500	$50.70	$25,350.00	132,797
1/3/2023	Adam J. Townsend	Insider	Sell	5,000	$50.70	$253,500.00	42,907
12/19/2022	Cedric Francois	CEO	Sell	28,200	$52.06	$1,468,092.00	965,128
12/15/2022	Alec Machiels	Director	Sell	1,250	$52.35	$65,437.50	263,774
12/8/2022	Pascal Deschatelets	Insider	Sell	12,000	$47.50	$570,000.00	970,280
12/5/2022	Adam J. Townsend	Insider	Sell	5,000	$50.38	$251,900.00	42,907
12/1/2022	A. Sinclair Dunlop	Director	Sell	500	$49.93	$24,965.00	129,430
12/1/2022	Federico Grossi	Insider	Sell	2,500	$49.93	$124,825.00	97,384
11/8/2022	Pascal Deschatelets	Insider	Sell	12,000	$46.47	$557,640.00	963,780
11/3/2022	Adam J. Townsend	Insider	Sell	5,000	$58.54	$292,700.00	42,907
10/14/2022	Alec Machiels	Director	Sell	1,250	$59.31	$74,137.50	263,774
10/10/2022	Pascal Deschatelets	Insider	Sell	12,000	$57.50	$690,000.00	957,280
10/3/2022	Federico Grossi	Insider	Sell	2,500	$66.69	$166,725.00	102,384
9/15/2022	Alec Machiels	Director	Sell	1,250	$66.00	$82,500.00	263,774
9/8/2022	Pascal Deschatelets	Insider	Sell	12,000	$63.98	$767,760.00	950,780
8/17/2022	Mark Jeffrey DeLong	SVP	Sell	5,000	$69.50	$347,500.00	29,250
8/15/2022	Adam J. Townsend	Insider	Sell	12,500	$69.00	$862,500.00	42,907
8/15/2022	Alec Machiels	Director	Sell	1,250	$67.21	$84,012.50	263,774
8/11/2022	A. Sinclair Dunlop	Director	Sell	30,000	$65.63	$1,968,900.00	255,679
8/11/2022	Adam J. Townsend	Insider	Sell	12,500	$67.00	$837,500.00	42,907
8/11/2022	Mark Jeffrey DeLong	SVP	Sell	5,000	$67.00	$335,000.00	29,250
8/3/2022	Adam J. Townsend	Insider	Sell	5,000	$56.43	$282,150.00	37,907
8/1/2022	Federico Grossi	Insider	Sell	2,500	$55.99	$139,975.00	107,384
7/27/2022	Mark Jeffrey DeLong	SVP	Sell	5,000	$57.00	$285,000.00	29,250
7/19/2022	Mark Jeffrey DeLong	SVP	Sell	5,000	$56.42	$282,100.00	29,250
7/15/2022	Alec Machiels	Director	Sell	1,250	$46.33	$57,912.50	263,774
7/11/2022	Adam J. Townsend	Insider	Sell	5,000	$48.42	$242,100.00	42,907
7/8/2022	Pascal Deschatelets	Insider	Sell	12,000	$47.95	$575,400.00	937,780
6/27/2022	A. Sinclair Dunlop	Director	Sell	1,341	$46.79	$62,745.39	1,341
6/23/2022	A. Sinclair Dunlop	Director	Sell	15,000	$45.00	$675,000.00	285,679
6/22/2022	David O. Watson	General Counsel	Sell	10,000	$44.51	$445,100.00	115,569
6/17/2022	Victoria L Brown	Insider	Sell	2,698	$45.00	$121,410.00	24,974
6/16/2022	Mark Jeffrey DeLong	SVP	Sell	10,000	$41.78	$417,800.00	29,250
6/15/2022	Alec Machiels	Director	Sell	1,250	$39.29	$49,112.50	263,774
6/8/2022	Pascal Deschatelets	Insider	Sell	12,000	$44.09	$529,080.00	891,775
6/1/2022	Federico Grossi	Insider	Sell	2,500	$41.78	$104,450.00	109,561
5/27/2022	Lukas Scheibler	Insider	Sell	10,000	$43.00	$430,000.00	40,358

See Full Table

SEC Filings (Institutional Ownership Changes) for Apellis Pharmaceuticals (NASDAQ:APLS)

96.29% of Apellis Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Apellis Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/29/2025	Rhumbline Advisers	124,454	$2.72M	0.0%	-0.9%	0.099%
5/21/2025	Acadian Asset Management LLC	23,976	$0.52M	0.0%	+1,146.2%	0.019%
5/20/2025	Focus Partners Wealth	21,883	$0.48M	0.0%	+118.4%	0.017%
5/19/2025	Bayforest Capital Ltd	52,338	$1.15M	0.5%	+431.9%	0.042%
5/19/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	222,634	$4.87M	0.0%	+4.6%	0.177%
5/16/2025	Woodline Partners LP	218,850	$4.79M	0.0%	+15.5%	0.174%
5/16/2025	Octagon Capital Advisors LP	2,094,000	$45.80M	4.9%	-30.4%	1.666%
5/16/2025	Voleon Capital Management LP	30,191	$0.66M	0.1%	N/A	0.024%
5/16/2025	Goldman Sachs Group Inc.	307,709	$6.73M	0.0%	+26.6%	0.245%
5/16/2025	Teza Capital Management LLC	11,855	$0.26M	0.1%	N/A	0.009%
5/16/2025	Millennium Management LLC	451,973	$9.89M	0.0%	-30.1%	0.360%
5/16/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	29,559	$0.67M	0.0%	+207.4%	0.024%
5/16/2025	Granahan Investment Management LLC	175,696	$3.84M	0.2%	+13.8%	0.140%
5/16/2025	EFG Asset Management North America Corp.	39,363	$0.86M	0.1%	-8.8%	0.031%
5/16/2025	EcoR1 Capital LLC	11,895,808	$260.16M	15.4%	+0.0%	9.465%
5/16/2025	AQR Capital Management LLC	4,077,419	$89.17M	0.1%	+119.6%	3.244%
5/16/2025	Alyeska Investment Group L.P.	150,000	$3.28M	0.0%	N/A	0.119%
5/16/2025	683 Capital Management LLC	333,000	$7.28M	0.5%	-22.8%	0.265%
5/16/2025	ADAR1 Capital Management LLC	17,000	$0.37M	0.1%	+13.3%	0.014%
5/15/2025	PDT Partners LLC	195,165	$4.27M	0.3%	+41.7%	0.155%
5/15/2025	Braidwell LP	1,652,334	$36.14M	1.3%	-21.3%	1.315%
5/15/2025	Focus Partners Advisor Solutions LLC	16,567	$0.36M	0.0%	N/A	0.013%
5/15/2025	Royal Bank of Canada	794,935	$17.38M	0.0%	-47.7%	0.632%
5/15/2025	Graham Capital Management L.P.	28,136	$0.62M	0.0%	N/A	0.022%
5/15/2025	Baird Financial Group Inc.	55,529	$1.21M	0.0%	+1.6%	0.044%
5/15/2025	Canada Pension Plan Investment Board	1,048,700	$22.94M	0.0%	+2,879.3%	0.834%
5/15/2025	Siren L.L.C.	2,578,396	$56.39M	3.3%	-8.4%	2.052%
5/15/2025	Trexquant Investment LP	384,922	$8.42M	0.1%	+89.6%	0.306%
5/15/2025	Landscape Capital Management L.L.C.	38,988	$0.85M	0.1%	-22.0%	0.031%
5/14/2025	Ieq Capital LLC	291,858	$6.38M	0.1%	+130.3%	0.232%
5/14/2025	Rafferty Asset Management LLC	180,134	$3.94M	0.0%	-25.4%	0.143%
5/14/2025	Old West Investment Management LLC	128,192	$2.80M	1.0%	+12.8%	0.102%
5/14/2025	Jump Financial LLC	265,593	$5.81M	0.1%	N/A	0.211%
5/14/2025	AlphaQuest LLC	56,104	$1.23M	0.1%	+226.5%	0.045%
5/14/2025	Kaufman Rossin Wealth LLC	9,577	$0.21M	0.1%	N/A	0.008%
5/14/2025	Candriam S.C.A.	159,054	$3.48M	0.0%	-70.5%	0.127%
5/14/2025	Hsbc Holdings PLC	24,999	$0.55M	0.0%	-80.4%	0.020%
5/13/2025	Northern Trust Corp	518,694	$11.34M	0.0%	-5.2%	0.413%
5/13/2025	Algert Global LLC	338,613	$7.41M	0.2%	+20.0%	0.269%
5/13/2025	Fox Run Management L.L.C.	15,712	$0.34M	0.1%	N/A	0.013%
5/13/2025	Russell Investments Group Ltd.	38,903	$0.85M	0.0%	+537.0%	0.031%
5/12/2025	Nuveen LLC	492,238	$10.77M	0.0%	N/A	0.392%
5/12/2025	Aigen Investment Management LP	15,621	$0.34M	0.1%	N/A	0.012%
5/12/2025	Invesco Ltd.	641,397	$14.03M	0.0%	+6.3%	0.510%
5/12/2025	Connor Clark & Lunn Investment Management Ltd.	131,895	$2.89M	0.0%	+878.6%	0.105%
5/12/2025	National Bank of Canada FI	782,701	$17.12M	0.0%	-43.5%	0.623%
5/12/2025	Swiss National Bank	132,600	$2.90M	0.0%	-7.7%	0.106%
5/9/2025	Deutsche Bank AG	1,776,576	$38.85M	0.0%	-0.1%	1.414%
5/9/2025	Charles Schwab Investment Management Inc.	964,499	$21.09M	0.0%	-3.2%	0.767%
5/9/2025	Vanguard Group Inc.	10,130,356	$221.55M	0.0%	+0.8%	8.060%
5/9/2025	Legacy Capital Group California Inc.	9,554	$0.21M	0.1%	+32.8%	0.008%
5/9/2025	ING Groep NV	184,200	$4.03M	0.0%	N/A	0.147%
5/9/2025	J. Safra Sarasin Holding AG	47,096	$1.03M	0.0%	-22.0%	0.037%
5/8/2025	US Bancorp DE	2,345	$51K	0.0%	-27.2%	0.002%
5/7/2025	Mackenzie Financial Corp	41,533	$0.91M	0.0%	+14.2%	0.033%
5/6/2025	Assetmark Inc.	1,252	$27K	0.0%	+3,938.7%	0.001%
5/6/2025	KLP Kapitalforvaltning AS	13,000	$0.28M	0.0%	-17.7%	0.010%
5/6/2025	Universal Beteiligungs und Servicegesellschaft mbH	16,159	$0.35M	0.0%	N/A	0.013%
5/6/2025	Y Intercept Hong Kong Ltd	29,577	$0.65M	0.0%	N/A	0.024%
5/5/2025	Jennison Associates LLC	2,477,531	$54.18M	0.0%	-10.2%	1.971%
5/2/2025	Victory Capital Management Inc.	215,152	$4.71M	0.0%	-61.7%	0.171%
5/2/2025	Edgestream Partners L.P.	241,287	$5.28M	0.2%	+119.6%	0.192%
5/1/2025	CWM LLC	98,258	$2.15M	0.0%	+120.3%	0.078%
5/1/2025	Arizona State Retirement System	19,539	$0.43M	0.0%	-7.9%	0.016%
5/1/2025	Xponance Inc.	16,097	$0.35M	0.0%	+14.4%	0.013%
4/30/2025	Cerity Partners LLC	54,444	$1.19M	0.0%	+16.7%	0.043%
4/30/2025	China Universal Asset Management Co. Ltd.	25,176	$0.55M	0.1%	-4.5%	0.020%
4/29/2025	Envestnet Asset Management Inc.	43,717	$0.96M	0.0%	+56.4%	0.035%
4/29/2025	Bank of New York Mellon Corp	329,173	$7.20M	0.0%	-1.6%	0.262%
4/29/2025	GF Fund Management CO. LTD.	3,185	$70K	0.0%	+21.9%	0.003%
4/28/2025	Teacher Retirement System of Texas	18,459	$0.40M	0.0%	-14.7%	0.015%
4/25/2025	KBC Group NV	3,850	$84K	0.0%	-96.3%	0.003%
4/24/2025	Diversified Trust Co	12,878	$0.28M	0.0%	N/A	0.010%
4/23/2025	Lecap Asset Management Ltd.	10,759	$0.24M	0.1%	N/A	0.009%
4/16/2025	Wealth Enhancement Advisory Services LLC	70,159	$1.53M	0.0%	+108.8%	0.056%
4/15/2025	Assenagon Asset Management S.A.	74,325	$1.63M	0.0%	+147.8%	0.059%
4/15/2025	SG Americas Securities LLC	366,144	$8.01M	0.0%	+2,004.2%	0.292%
4/14/2025	Pallas Capital Advisors LLC	42,534	$0.93M	0.0%	+218.2%	0.034%
4/10/2025	Hennion & Walsh Asset Management Inc.	44,166	$0.97M	0.0%	+48.5%	0.035%
4/9/2025	Merit Financial Group LLC	33,762	$0.74M	0.0%	+324.4%	0.027%
4/8/2025	Rhumbline Advisers	124,454	$2.72M	0.0%	-0.9%	0.099%
4/7/2025	GAMMA Investing LLC	10,235	$0.22M	0.0%	+1,795.4%	0.008%
3/18/2025	California State Teachers Retirement System	70,688	$2.26M	0.0%	-7.6%	0.056%
3/17/2025	Wealth Enhancement Advisory Services LLC	33,594	$1.07M	0.0%	+140.8%	0.027%
2/20/2025	Mackenzie Financial Corp	36,358	$1.16M	0.0%	-20.1%	0.029%
2/19/2025	Toronto Dominion Bank	997,053	$31.82M	0.1%	+3,791.4%	0.802%
2/19/2025	GF Fund Management CO. LTD.	2,612	$83K	0.0%	N/A	0.002%
2/19/2025	Public Employees Retirement System of Ohio	35,872	$1.15M	0.0%	-5.4%	0.029%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	212,887	$6.79M	0.0%	+11.4%	0.171%
2/17/2025	Voloridge Investment Management LLC	345,885	$11.04M	0.0%	-57.5%	0.278%
2/17/2025	Woodline Partners LP	189,477	$6.05M	0.0%	+0.5%	0.152%
2/17/2025	Vident Advisory LLC	14,564	$0.47M	0.0%	N/A	0.012%
2/17/2025	Squarepoint Ops LLC	166,962	$5.33M	0.0%	+84.8%	0.134%
2/17/2025	Toronto Dominion Bank	997,053	$31.82M	0.1%	+3,791.4%	0.802%
2/17/2025	Suvretta Capital Management LLC	793,187	$25.31M	0.9%	N/A	0.638%
2/17/2025	Sphera Funds Management LTD.	206,251	$6.58M	1.2%	-4.5%	0.166%
2/17/2025	Royal Bank of Canada	1,518,827	$48.47M	0.0%	+969.6%	1.221%
2/17/2025	Rafferty Asset Management LLC	241,474	$7.71M	0.0%	+18.3%	0.194%
2/17/2025	Point72 Asset Management L.P.	1,267,958	$40.46M	0.1%	N/A	1.019%
2/17/2025	Point72 Europe London LLP	192,694	$6.15M	0.4%	N/A	0.155%

Data available starting January 2016

See Full Table

Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. It offers EMPAVELI for the treatment of paroxysmal nocturnal hemoglobinuria, C3 glomerulopathy and immune complex membranoproliferative glomerulonephritis, and hematopoietic stem cell transplantation-associated thrombotic microangiopathy; and SYFOVRE for treating geographic atrophy secondary to age-related macular degeneration and geographic atrophy (GA). The company also develops APL-3007, a small interfering RNA, or siRNA, which is in a Phase 1 clinical trial, as well as an oral complement inhibitor that is in preclinical development. It has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) for development and commercialization of pegcetacoplan; and a collaboration with Beam Therapeutics Inc. focused on the use of Beam's base editing technology to discover new treatments for complement-driven diseases. The company was incorporated in 2009 and is based in Waltham, Massachusetts.

Today's Range

Now: $16.92

$16.69

$17.37

50 Day Range

MA: $19.05

$16.36

$24.28

52 Week Range

Now: $16.92

$16.10

$43.76

Volume

1,431,738 shs

Average Volume

2,272,764 shs

Market Capitalization

$2.13 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.73

Who are the company insiders with the largest holdings of Apellis Pharmaceuticals?: Apellis Pharmaceuticals' top insider investors include:
Pascal Deschatelets (Insider)
Cedric Francois (CEO)
Alec Machiels (Director)
A Sinclair Dunlop (Director)
David O Watson (General Counsel)
Timothy Eugene Sullivan (CFO)
Adam J Townsend (Insider)
Nur Nicholson (Insider)
Mark Jeffrey Delong (Insider)
Jeffrey Eisele (Insider)
Lukas Scheibler (Insider)
Caroline Baumal (Insider)
James George Chopas (CAO)
Karen Lewis (Insider)
Learn More about top insider investors at Apellis Pharmaceuticals.
Who are the major institutional investors of Apellis Pharmaceuticals?: Apellis Pharmaceuticals' top institutional shareholders include:
EcoR1 Capital LLC — 9.47%
Vanguard Group Inc. — 8.06%
AQR Capital Management LLC — 3.24%
Siren L.L.C. — 2.05%
Jennison Associates LLC — 1.97%
Octagon Capital Advisors LP — 1.67%
Learn More about top institutional investors of Apellis Pharmaceuticals stock.
Which institutional investors are selling Apellis Pharmaceuticals stock?: Within the last quarter, APLS stock was sold by these institutional investors:
Octagon Capital Advisors LP
Royal Bank of Canada
National Bank of Canada FI
Braidwell LP
Candriam S.C.A.
Victory Capital Management Inc.
Jennison Associates LLC
Siren L.L.C.
In the last year, company insiders that have sold Apellis Pharmaceuticals company stock include:
Pascal Deschatelets (Insider)
Cedric Francois (CEO)
Alec Machiels (Director)
A Sinclair Dunlop (Director)
David O Watson (General Counsel)
Timothy Eugene Sullivan (CFO)
Adam J Townsend (Insider)
Nur Nicholson (Insider)
Mark Jeffrey Delong (Insider)
Learn More investors selling Apellis Pharmaceuticals stock.
Which institutional investors are buying Apellis Pharmaceuticals stock?: During the previous quarter, APLS stock was purchased by institutional investors including:
AQR Capital Management LLC
Canada Pension Plan Investment Board
Nuveen LLC
SG Americas Securities LLC
Jump Financial LLC
ING Groep NV
Trexquant Investment LP
Ieq Capital LLC